. The company’s pipeline includes four scientific-stage therapies. Its most advanced drug applicant is ROS1 inhibitor taletrectinib for treating lung cancer. Nuvation is finishing two section 2 pivotal studies on taletrectinib.Musk arrived at an acquisition deal with Twitter in April, but over the following weeks, he lifted issues over spam accou